Center-Authored Papers

Filters: Author is Blish, Catherine A  [Clear All Filters]
Journal Article
Blish CA, Dogan OC, Jaoko W, McClelland SR, Mandaliya K, Odem-Davis K, Richardson BA, Overbaugh J.  2014.  Association between Cellular Immune Activation, Target Cell Frequency, and Risk of Human Immunodeficiency Virus Type-1 Superinfection.. Journal of virology. 88(10):5894-9. Abstract
Lynch JB, Nduati R, Blish CA, Richardson BA, Mabuka JM, Jalalian-Lechak Z, John-Stewart G, Overbaugh J.  2011.  The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection.. Journal of virology. 85(11):5252-61. Abstract
Piantadosi A, Panteleeff D, Blish CA, Baeten JM, Jaoko W, McClelland SR, Overbaugh J.  2009.  Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.. Journal of virology. 83(19):10269-74. Abstract
Blish CA, Dogan OC, Jaoko W, McClelland SR, Mandaliya K, Odem-Davis KS, Richardsonb BA, Overbaugh J.  2012.  Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.. AIDS (London, England). 26(5):643-6. Abstract
Blish CA, Sangaré L, Herrin BR, Richardson BA, John-Stewart G, Walson JL.  2010.  Changes in plasma cytokines after treatment of ascaris lumbricoides infection in individuals with HIV-1 infection.. The Journal of infectious diseases. 201(12):1816-21. Abstract
Blish CA, Sather ND, Sellhorn G, Stamatatos L, Sun Y, Srivastava I, Barnett SW, Cleveland B, Overbaugh J, Hu S-lok.  2010.  Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes.. Journal of virology. 84(5):2573-84. Abstract
Blish CA, Jalalian-Lechak Z, Rainwater S, Nguyen M-A, Dogan OC, Overbaugh J.  2009.  Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1.. Journal of virology. 83(15):7783-8. Abstract
Blish CA, McClelland SR, Richardson BA, Jaoko W, Mandaliya K, Baeten JM, Overbaugh J.  2012.  Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.. Journal of acquired immune deficiency syndromes (1999). 61(4):436-40. Abstract
Blish CA, Dogan OC, Derby NR, Nguyen M-A, Chohan B, Richardson BA, Overbaugh J.  2008.  Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.. Journal of virology. 82(24):12094-103. Abstract
Lovelace E, Xu H, Blish CA, Strong RK, Overbaugh J.  2011.  The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization.. Virology. 421(2):235-44. Abstract
Lehman DA, Ronen K, Blish CA, Baeten JM, Jalalian-Lechak Z, Jaoko W, Mandaliya K, Richardson BA, McClelland SR, Overbaugh J.  2014.  Systemic Cytokine Levels Show Limited Correlation with Risk of HIV-1 Acquisition.. Journal of acquired immune deficiency syndromes (1999). Abstract